This DLD Summer panel discussion takes a deep dive into the converging worlds of health, medicine and technology.
Merck Group CTO Laura Matz and Brainlab founder Stefan Vilsmeier provide expert opinions on the most exciting and promising new areas where technology can aid human health.
In conversation with Techonomy founder David Kirkpatrick, they also discuss privacy, regulation, and access to data – for example to speed up drug discovery with the help of artificial intelligence.
Dr. Laura Matz is the Chief Science and Technology Officer for Merck, driving innovation and digitalization in Merck across the three business sectors of Life Sciences, Healthcare and Electronics. She has 20 years of experience in semiconductor manufacturing and a decade of experience running semiconductor materials businesses.
A journalist and media entrepreneur, David Kirkpatrick founded Techonomy Media, which he led for 12 years. He is now focusing on climate tech, climate action, and the crisis of global heating. Kirkpatrick’s bestselling book The Facebook Effect has been published in 32 languages.
Stefan Vilsmeier is the founder, president and CEO of Brainlab. Since its founding in 1989, Brainlab has evolved into an international leader in medical technology with over 1,400 employees in 18 offices around the globe. The company leverages 3D computer imaging to facilitate precision surgery.
